Thomas Hamilton

Mr. Thomas E.
Hamilton is an Independent Director at Larimar Therapeutics, Inc., an Independent Chairman at Annaly Capital Management, Inc., a Director & Owner at Construction Forms, Inc. and a Chairman at Chondrial Therapeutics Holdings LLC.
He is on the Board of Directors at Larimar Therapeutics, Inc., Construction Forms, Inc. and The Friedreich's Ataxia Research Alliance.
Mr. Hamilton was previously employed as a Chairman by Chondrial Therapeutics, Inc., a Head of Securitized Products Trading by Barclays Capital, Inc., a Managing Director by Citigroup, Inc., a Co-Founder by CureFA Foundation, and a Managing Director by Salomon Brothers, Inc. He received his undergraduate degree from the University of Dayton.